Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

INO US Equity

Inovio Pharmaceuticals, Inc.Health Care · Pharmaceutical Preparations · CIK 1055726 · FY ends Dec 31
$1.30
+0.10 (+8.33%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 4 13G
DateEventWhat happened / filerSource
2026-08-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-1213G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Adage Capital Management, L.P.sec.gov ↗
2026-08-0713GSchedule 13G filed — ≥5% beneficial owner (passive) · by RA CAPITAL MANAGEMENT, L.P.sec.gov ↗
2026-08-0613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-07-3113GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
2026-07-318-K 8.01Other eventssec.gov ↗
2026-07-318-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-07-298-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-29

Every row is a filed document, checked against its EDGAR index.